Ascendant Solutions (OTCMKTS:MYDP) vs. Charles River Laboratories International (NYSE:CRL) Head-To-Head Review

Charles River Laboratories International (NYSE:CRL) and Ascendant Solutions (OTCMKTS:MYDP) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation.

Profitability

This table compares Charles River Laboratories International and Ascendant Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Charles River Laboratories International	-2.07%	15.78%	7.02%
Ascendant Solutions	N/A	N/A	N/A

Earnings & Valuation

This table compares Charles River Laboratories International and Ascendant Solutions”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charles River Laboratories International	$4.05 billion	2.63	$22.20 million	($1.56)	-138.96
Ascendant Solutions	N/A	N/A	N/A	N/A	N/A

Charles River Laboratories International has higher revenue and earnings than Ascendant Solutions.

Institutional and Insider Ownership

98.9% of Charles River Laboratories International shares are owned by institutional investors. 1.3% of Charles River Laboratories International shares are owned by company insiders. Comparatively, 31.6% of Ascendant Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Charles River Laboratories International and Ascendant Solutions, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charles River Laboratories International	1	4	10	0	2.60
Ascendant Solutions	0	0	0	0	0.00

Charles River Laboratories International presently has a consensus target price of $209.46, indicating a potential downside of 3.37%. Given Charles River Laboratories International’s stronger consensus rating and higher possible upside, analysts plainly believe Charles River Laboratories International is more favorable than Ascendant Solutions.

Summary

Charles River Laboratories International beats Ascendant Solutions on 7 of the 9 factors compared between the two stocks.

About Charles River Laboratories International

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

About Ascendant Solutions

Dougherty's Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas.